The Role of Pharmacogenomics in Optimizing Chemotherapy Regimens: Mt. Sinai Hospital
April 17, 2026
At the Hospital or Via Zoom
Target Audience
All pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
Describe the role of DPYD and UGT1A1 enzymes in the metabolism of various chemotherapy agents
Identify toxicities related to poor or intermediate metabolism of chemotherapy
State the use of pharmacogenomic testing for patients starting chemotherapy
Describe how to mitigate dose adjustments for pharmacogenomic polymorphisms
Zoom or Hospital
NY
12866
United States
Marina Samuel PharmD
PGY2 Mount Sinai
UAN# 0042-0000-26-015-L01-P
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Facebook
X
LinkedIn
Forward